SUMMARY To assess the physiological role of atrial natriuretic factors in blood pressure regulation, we studied the effect of chronic infusion of a synthetic atrial natriuretic factor of 25 amino acid residues (Arg 102-Tyr 126) in rats with angiotensin H-induced hypertension. Rats were studied while on a normal sodium diet or during sodium loading with 1% NaCl solution used as drinking water. Systolic blood pressure decreased slightly during combined infusion of synthetic atrial natriuretic factor, 150 ju.g/kg/day, and angiotensin II, 900 /xg/kg/day. This effect was sustained for 3 days in rats receiving a regular sodium intake (p<0.01) and during sodium loading (p<0.01). Administration of synthetic atrial natriuretic factor to rats made hypertensive by a 3-day infusion of angiotensin II reduced blood pressure slightly, but not to control levels, and this effect was sustained for the remaining 3 days of the experiment in both dietary groups. These results indicate that a nonhypotensive dose of synthetic atrial natriuretic factor can modulate the vasopressor effect of angiotensin II. Thus, the attenuating effect may be involved in blood pressure regulation independently of sodium metabolism, although its actual physiological importance remains undetermined. (Hypertension 8: 748-753, 1986) KEY WORDS angiotensin II rat atrial natriuretic factor vascular smooth muscle blood pressure • sodium-water excretion A TRIAL natriuretic factor (ANF) is a potent na-/ \ triuretic and diuretic substance present in spe-X \~ cific granules of mammalian atrial cardiocytes.
of these peptides has become possible. Recently, by using ANF of 25 amino acid residues (Arg 102-Tyr 126) synthesized by Sugiyama et al. 10 and proven to have the same chemical characteristics and biological activities as natural ANF extracted from rat atrium and sequenced by Misono et al., 9 we demonstrated that a nonhypotensive dose of synthetic ANF inhibits the hypertension induced by chronic NE infusion in conscious rats."
In the present study, we tried to evaluate the effect of chronic infusion of a synthetic ANF of 25 amino acid residues in conscious rats made hypertensive by chronic ANG II infusion.
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mEq/g; potassium, 0.27 mEq/g; Oriental CMF, Oriental Yeast, Tokyo, Japan) and had free access to tap water. Studies were performed after a 7-day period of acclimatization to the housing, feeding, and drinking conditions. Two protocols were used to assess the effect of ANF on ANG II-induced hypertension in conscious rats on a regular diet as well as during sodium loading with 1% NaCl solution administered as drinking water. In the first protocol, ANG II and ANF were infused simultaneously and the change in blood pressure was compared with that in rats receiving ANG II plus vehicle. After a 7-day control period, rats were either placed on a regular diet or subjected to sodium loading. After a subsequent 7-day period, the rats were infused with ANG II, 900 /ig/kg/day, dissolved in 0.01 N acetic acid plus ANF, 150 /Ag/kg/day, dissolved in physiological saline or with ANG II plus vehicle for up to 3 days. The ANF or vehicle infusion was stopped after 3 days by disconnecting the osmotic minipumps filled with ANF or vehicle, while the ANG II infusion was continued for another 3 days.
In the second protocol, rats were made hypertensive by a 3-day infusion of ANG II while receiving a regular diet or undergoing sodium loading. On Day 3, rats were challenged by a 3-day ANF infusion. Control rats received physiological saline instead of ANF.
Synthetic ANF (150 /u.g/kg/day), dissolved in physiological saline, or vehicle was delivered by an osmotic minipump (Alzet, Palo Alto, CA, USA) into the jugular vein. With the rat under pentobarbitone sodium (Abbott Laboratories, Tokyo, Japan) anesthesia, a vascular catheter (PE-60) was tunneled subcutaneously and the osmotic minipump was implanted in the interscapular region of the rat's back. This ANF of 25 amino acid residues (Arg 102-Tyr 126), synthesized by Sugiyama et al., 10 has been shown to have chemical characteristics and biological activities that match those of natural ANF extracted from rat atrium and sequenced by Misono et al. 9 The nonhypotensive dose of ANF was chosen by performing a continuous infusion of synthetic ANF at doses of0.1,0.3, 1, and5 /xg/kg/min for up to 30 minutes in rats anesthetized with thiobutabarbital (Inactin) and confirming that levels of 0.1 and 0.3 /xg/kg/min induced significant diuresis and natriuresis but did not affect the blood pressure significantly. Based on the assumptions that ANF did not degrade during the study and that the pumps dispensed fluid at a rate of approximately 1 /nl/hr, the chosen infusion dose (150 /xg/kg/day) should have been sufficient to induce a small but significant diuresis and natriuresis with no affect on blood pressure in a rat bioassay system. As reported previously," however, continuous infusion of ANF (150 /i.g/kg/day) into the jugular vein by osmotic minipumps did not induce any changes in systolic blood pressure, urine volume, and urinary sodium excretion for up to 3 days when compared with values in vehicle-infused rats (Table 1 ). The stability of ANF in the osmotic minipump was examined by comparing the diuretic and natriuretic activities of freshly dissolved ANF with those in the ANF solution recovered from the minipump after 3 days of use in the rat; no difference in activities was observed.
[Ile 5 ]angiotensin II (Protein Research Foundation, Osaka, Japan) was dissolved in 0.01 N acetic acid and delivered intraperitoneally by another osmotic minipump placed in the abdominal cavity through a midline incision, which was then closed with autoclips. In preliminary experiments to determine the minimum pressor dose of ANG II needed to maintain an elevation of blood pressure, we assessed continuous ANG II infusions at doses of 75, 100, 150, and 200 ng/min for up to 6 days in conscious rats. Systolic blood pressure increased progressively at ANG II levels of 100, 150, and 200 ng/min, whereas the changes in systolic blood pressure induced by ANG II, 75 ng/min, did not differ from those induced by vehicle infusion. Based on the assumptions that ANG II did not degrade during the study and that the pumps dispensed fluid at a rate of approximately 1 /xl/hr, the infusion dose (900 /i,g/kg/ day) should have been sufficient to induce small but 
FIGURE 1. Effect of atrial natriuretic factor (ANF) on the hypertension induced by chronic infusion of angiotensin II (ANG II) in conscious rats on a regular diet (A) and during sodium loading with 1% NaCl solution used as drinking water (B). Rats were infused with ANG II (900 /xg/kg/day) plus ANF (150 ng/kg/day; m) ANG II plus vehicle (A), or vehicle alone (*). Results are means ± SEM. Analysis of variance for repeated measurements revealed a significant change in systolic blood pressure in rats given ANG II and ANF compared with that in rats given ANG II and vehicle on a regular diet (p<0.0I) and during sodium loading (p<0.01). Asterisk (p<0.05), dagger (p<0.01), and double dagger (p<0.001) indicate significant difference compared with values in rats given ANG II and vehicle. All = ANG 11.
significant elevations of blood pressure in conscious rats. Chronic infusion of this level of ANG II has previously been shown 12 to induce a sustained increase in systolic blood pressure in conscious rats.
Systolic blood pressure in the rats was recorded daily using an indirect tail-cuff method without anesthesia. 13 The daily fluid intake, urine volume, and urinary sodium excretion also were determined. All results are expressed as means ± SEM. Statistical analysis of the data between groups was performed by two-way analysis of variance for repeated measurements. Statistically significant differences on each day were isolated by the Newman-Keuls test for multiple comparisons of each value.
Results
Before the combined infusion of ANG II and ANF, or ANG II and vehicle, during both a regular diet and sodium loading with 1% NaCl, systolic blood pressure, weight, water intake, urine volume, and urinary sodium excretion were not significantly different between groups ( Figure 1 , Table 2 ). Neither were these variables significantly different between groups subjected to chronic ANG II infusion before the infusion of ANF or vehicle during either diet ( Figure 2 , Table 3 ).
As shown in Figure 1 , the systolic blood pressure of the group given ANG II and vehicle began to rise significantly on the first day of the infusion and remained high until the third day during either diet (p<0.01), whereas values in the vehicle-treated rats did not change. When ANF, 150 /ig/kg/day, was administered simultaneously with ANG II, 900 £ig/kg/ day, the elevation of systolic blood pressure was slightly attenuated. This effect was sustained for up to 3 days in rats receiving a regular diet (p<0.01) or subjected to sodium loading (p<0.01) compared with the rise seen during ANG II and vehicle infusion during both sodium conditions. However, systolic blood pressure in the group given ANG II and ANF was significantly higher than that in vehicle-treated rats during either diet (p < 0.01). Withdrawal of ANF after 3 days of combined ANG II and ANF infusion promptly returned systolic blood pressure to the levels in ANG II plus vehicle-infused rats subjected to either sodium condition. The attenuating effect of ANF on blood pressure in ANG II-infused rats subjected to either sodium condition was not associated with any significant changes in urine volume and urinary sodium excretion (see Table 2 ).
As shown in Figure 2 , the administration of ANF to rats made hypertensive by a 3-day infusion of ANG II reduced the blood pressure slightly (but not to control levels). This effect was sustained for the remaining 3 experimental days in rats on either diet (/?<0.01) and was significantly different from the response in rats given ANG II plus vehicle on either diet. However, systolic blood pressure of rats given ANG II and ANF was significantly higher than that of the vehicleinfused rats on either diet (p<0.0\). The attenuating effect of ANF on blood pressure in ANG II-infused rats on either diet was not associated with any significant changes in urine volume and urinary sodium excretion (see Table 3 ).
Discussion
We reported previously that continuous infusion of a nonhypotensive dose of a synthetic ANF of 25 amino acid residues abolished the hypertensive effect of chronic NE infusion and returned the blood pressure to control levels, and that the antihypertensive effect was independent of ANF-induced renal effects." In the present study, we demonstrated that the administration of the same dose of synthetic ANF employed in our previous study" reduced slightly but significantly the blood pressure in ANG II-infused rats receiving regular intake of sodium or subjected to sodium loading with 1% NaCl solution given as drinking water. This attenuation in the blood pressure elevation induced by chronic ANG II infusion was not accompanied by diuresis or natriuresis, suggesting, as in our previous report," that the slight reduction of blood pressure is not secondary to the renal effects of this peptide. Furthermore, the antihypertensive effect of a nonhypotensive dose of ANF was less prominent in ANG II-infused rats in the present study than in NE-infused rats in our previous study."
Since the 1981 report of DeBold et al., 14 several 
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Weight (g) ANG II + vehicle (n = 6) ANG II + ANF(n = 6) Water intake (ml/day) ANG II + vehicle (n = 6) ANG II + ANF(n = 6) Urine volume (ml/day) ANG II + vehicle (n = 6) ANG II + ANF (n = 6) U Nl V (mEq/day) ANG 11 + vehicle (n = 6) ANG 11 + ANF(n = 6) Results are means ± SEM. ANG II = angiotensin II; ANF = atrial natriuretic factor; U N ,V = urinary sodium excretion. studies have demonstrated the blood pressure-reducing effect of ANF. However, much of the information about the effects of ANF on blood pressure regulation is derived from short-term studies using isolated perfused organs, anesthetized animals subjected to surgical stress, or pharmacological doses of ANF and may not be applicable to more physiological settings. In addition, few studies have assessed the chronic effects of ANF in experimental models of hypertension. Recently, Garcia et al." reported that chronic infusion of synthetic ANF (ANF 8-33) for 7 days gradually reduced blood pressure in conjunction with a significant decrease in plasma renin activity in two-kidney, one clip Goldblatt hypertensive rats. They suggested that the hypotensive response to ANF was due mainly to vasodilatation, although they could not exclude the possibility that the decrease in plasma renin activity played some role in lowering blood pressure. In addition, Volpe et al. 16 showed that synthetic ANF (auriculin A) exerts a potent blood pressure-lowering effect in renin-dependent, two-kidney, one clip Goldblatt hypertensive rats, while much lower reductions in blood pressure occurred in one-kidney, one clip Goldblatt hypertensive rats, a model characterized by a similar degree of hypertension that is not renin-dependent. 17 These observations may be consistent with the previous findings, observed in vitro in isolated aortic strips, that ANF more profoundly attenuated the effects of ANG II than those of other vasoconstrictors. 3 To our knowledge, no information about the effect of prolonged elevation of ANF on the hypertension induced by chronic ANG II infusion is available. The present findings, showing a weak antihypertensive effect of ANF in ANG II-infused rats, suggest that the attenuating effect of ANF on the vascular action induced by chronic ANG II administration is not the only cause of the marked blood pressure reduction in renindependent, two-kidney, one clip Goldblatt hypertensive rats. The precise mechanism of the role of ANF in blood pressure regulation has not been elucidated in these models of hypertension. To our knowledge, the weak antihypertensive effect of ANF in rats made hypertensive by chronic ANG II infusion has not been reported previously, whereas it has been well documented that an in vitro preparation of ANF attenuates the vasoconstrictive effect of ANG II. 3 The suppression of hypertension provoked by chronic ANG II infusion was not due to tachyphylaxis per se, since ANG II induced a sustained increase in systolic blood pressure in the absence of ANF.
Sodium loading
FIGURE 2. Effect of atrial natriuretic factor (ANF) on the hypertension induced by chronic infusion of angiotensin II (ANG II) in conscious rats on a regular diet (A) and during sodium loading with 1% NaCl solution used as drinking water (B). Rats were infused with ANG II (900 pg/kg/day) alone (A), ANG II plus ANF (150 fig/kg/day; m) or ANG II plus vehicle (o) 3 days after the infusion of ANG II alone, or with vehicle alone (•). Results are means + SEM. Analysis of variance for repeated measurements revealed a significant change in systolic blood
The mechanism (or mechanisms) by which ANF attenuates the hypertension induced by chronic ANG II infusion was not elucidated by the present experiments. Although the substance has natriuretic and diuretic actions, 1 ' 2 -10> ' 4 we could not show significant changes in urine volume and urinary sodium excretion in ANG Il-infused rats during the ANF infusion under either sodium condition. Therefore, it appears unlikely that the antihypertensive effect of ANF is due to the loss of water and sodium. A possible explanation for the slight attenuating effect of ANF on ANG IIinduced hypertension could be a nonspecific action of ANF on the vascular smooth muscle, which might be induced by unphysiological levels of ANF. Its actual physiological level is unknown, however, and we did not evaluate the ANF blood levels in the present study.
The infusion dose of ANG II was chosen as sufficient to induce and maintain the blood pressure elevation and to be comparable to the level of blood pressure elevation induced by NE in our previous study." Surprisingly, the level of blood pressure elevation induced by ANG II in the present study was greater than that induced by NE. However, the molar dose of NE was approximately 10 times that of ANG II. This finding indirectly supports the possibility that NE is more sensitive than ANG II to the effects of ANF. As already noted, the antihypertensive effect of ANF was less prominent in ANG H-infused rats than in NE-infused rats. Since chronic hypertension induced by the administration of ANG II is not volume-dependent but is characterized by an increase in total peripheral resistance, as is the case in chronic NE-induced hypertension, 18 ANF may interfere with the intracellular mechanism causing vasoconstriction. Diz et al. 12 suggested that increased prostaglandin production during chronic ANG II infusion may be part of a homeostatic response that acts to minimize the ANG II-induced blood pressure elevation. Although we did not find that a synthetic ANF of 25 amino acid residues stimulated prostacyclin biosynthesis (unpublished observations), ANF has been reported to increase the levels of cyclic guanosine 3',5'-monophosphate in vascular smooth muscle cell.
1920 Therefore, the difference in the attenuating effect of ANF in ANG II-induced hypertension from that in NE-induced hypertension may be due to a different intracellular mechanism causing vasoconstriction, although the exact mechanism of the effect of ANF on vascular smooth muscle is unknown.
In conclusion, the present results, that continuous infusion of a nonhypotensive dose of a synthetic ANF slightly attenuated the hypertension produced by chronic ANG II infusion, suggest that the attenuating effects of ANF on the vascular action of ANG II play some role in the regulation of blood pressure. However, its actual physiological importance remains to be determined.
